Shanghai Shyndec Pharmaceutical Co.,Ltd.’s Net Profit Rose 5.6% in 2022

Shanghai Shyndec Pharmaceutical Co.,Ltd. (上海现代制药股份有限公司) (600420.SH) reported a net profit of 867.5 million yuan in 2022, up 5.6% year-on-year.

Meanwhile, the company posted 13 billion yuan in revenue, down 7.1% year-on-year.

At the end of the reporting period, it had 19.6 billion yuan in total assets and 7.5 billion yuan in total liabilities, with a liability-to-asset ratio of 38.1%.